PharmaCyte net loss widens to $19.42 million in FY26; revenue remains no revenuePUBT·Jul 29 at 04:20 PMPMCB-4.21%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·Jun 2 at 04:09 PMCPHI-3.70%NRXP+4.26%
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga_article·May 18 at 04:05 PMBLRX-1.26%NCNA-2.58%
07:30 ETPackGene to Present Advances in Scalable AAV Manufacturing, Analytical Innovation, and Novel Capsid Engineering at ASGCT 2026prnewswire·May 5 at 06:38 AMNKGN0.00%PRTG0.00%
Mankind Pharma shares gain 3% on acquiring Rivotril brand rights from RocheBusiness Standard·Mar 17 at 04:51 PMIHI-1.93%LONA+1.28%
PharmaCyte Biotech 10-Q: $0.0M Revenue, $(0.17) EPS (Q3), $(2.41) EPS (YTD)TradingView·Mar 17 at 02:51 PMPMCB-4.21%
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026 | PBSV Stock NewsStockTitan·Mar 17 at 08:05 AMLABD+10.54%IHE-2.19%
Cipher Pharmaceuticals Delivers Record 2025 Results and Primes for Next Acquisition PhaseTip Ranks·Mar 12 at 05:09 PMPBE-1.86%LABU-10.66%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Feb 26 at 03:05 PMPMCB-4.21%IBB-2.77%
PharmAla donates drugs for fibromyalgia trial to receive trial data from hospital affiliated with Harvard.Unusual Whales·Feb 26 at 07:27 AMPMCB-4.21%PBPH-1.85%
